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Abstract The gene for mouse polyomavirus large tumor (LT)
antigen, a potent oncoprotein, was expressed in Saccharomyces
cerevisiae from the inducible GAL1 promoter. Substantial cell
growth inhibition as well as colony and cell morphology changes
dependent on cyclic adenosine monophosphate (cAMP) were
observed. In contrast to cell and colony morphology alterations,
the growth inhibition appeared to be transient, thus indicating
the existence of an active adaptation of yeast cells to the LT
antigen presence.
" 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Budding yeast Saccharomyces cerevisiae with the fully se-
quenced genome, extensive molecular biology tools and a se-
ries of well-de¢ned mutants available from EUROSCARF
(http://www.uni-frankfurt.de/fb15/mikro/euroscarf) proved to
be a good and relatively simple model system for an inves-
tigation of functions of viral proteins of higher eukaryotes.
Because of the evolutionary conservation of many cellular
mechanisms (e.g. gene expression and its regulation or cell
cycle regulation), yeast cells might provide an opportunity
to identify interactions of viral proteins with cellular struc-
tures and connect them with molecular processes and their
control machinery [1^6]. Thus, evidence has been obtained
that several targets of the adenovirus E1A regulatory protein
are conserved between mammalian and budding yeast cells :
the expression of the adenovirus E1A protein in yeast cells led
to the ¢nding that E1A speci¢cally blocks SWI/SNF-depen-
dent transcriptional activation [7]. Miller et al. discovered that
the inhibition e¡ect of E1A on yeast cell growth is dependent
on the cyclic adenosine monophosphate (cAMP) signalling
pathway [8]. This appeared to be in parallel with the E1A
function in gene activation/repression in mammalian cells as
stimulation of cAMP-dependent protein kinase is absolutely
required for activation of the mouse c-fos and jun B genes by
the E1A protein [9].
Another viral regulatory protein ^ oncoprotein Tax of hu-
man T-lymphotropic virus type 1 (HTLV-1) has two major
functions during the HTLV-1 life cycle: it activates viral tran-
scription and deregulates the cellular mechanisms critical for
cell growth and division. Its expression in S. cerevisiae re-
sulted in a G2/M slow down or arrest and a loss of cell
viability. The results support the notion that Tax aberrantly
targets and activates APCCdc20p, leading to unscheduled deg-
radation of Pds1p/securin and Clb2p/cyclin B1 connected with
severe chromosome aneuploidy in yeast or human cells. These
results provided a molecular explanation for the frequent
chromosomal abnormalities in HTLV-1 infected T cells and
the highly aneuploid nature of adult T-cell leukemia cells [10].
Our studies have been focused on a multifunctional regu-
latory protein, large tumor (LT) antigen of mouse polyoma-
virus (PyV), a member of the Polyomaviridae family. The ge-
nome of this small non-enveloped DNA tumor virus encodes
only six gene products. Three non-structural proteins (LT,
middle tumor (MT) and small tumor (ST) antigens) were
shown to play roles in cell immortalization and transforma-
tion processes. LT antigen is an 88.1 kDa oncoprotein that
interacts with multiple host factors (at least two subunits of
DNA polymerase K primase, single-stranded DNA binding
protein, replication protein A, DNA topoisomerase I) to co-
ordinate the expression of viral genes and initiate replication
of the viral genome [11^15]. Besides a¡ecting viral transcrip-
tion and DNA replication, it in£uences the cell cycle, espe-
cially the entry into the mitotic cycle. In addition to other
cellular factors (CBP/p300 transcriptional co-activators
[16,17], hsc70 [18]), LT antigen interacts with one of the key
cell cycle regulators, tumor suppressor protein (p105Rb) as
well as with related proteins p107 and p130 [19^22]. Interac-
tion of LT antigen with the pRb protein family causes E2F
transcription factor release from the pRb^E2F complex and
leads to cell cycle progression from G0 or G1 into S phase
[23^25].
In contrast to PyV LT antigen, the LT antigen of a related
simian virus, SV40, interacts with another tumor suppressor
protein, p53 [26^31]. For SV40, studies using tsA mutants
demonstrated that LT antigen was required for both the ini-
tiation and maintenance of the transformed state [32,33]. PyV
LT antigen can immortalize cells ; however, the major trans-
forming protein is the membrane bound MT antigen (absent
in polyomaviruses of primates), which possesses the ability to
transform cells through its interactions with c-Src tyrosine
kinase and other proteins of the signal transduction pathway
[34]. Expression of SV40 LT in yeast cells led to the ¢ndings
that SV40 LT antigen interacts with an important cell cycle
regulator, p34CDC28, highly conserved protein kinase that con-
trols, together with the cyclins, di¡erent steps of progression
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of eukaryotic cells through the cell cycle (for review see [35]).
Fewer studies have been performed to understand immortal-
ization by PyV LT antigen, which does not bind p53. An
essential role in immortalization for the p105Rb binding activ-
ity of polyoma LT has been demonstrated. However, it is
likely that additional activities are also required. The S. cere-
visiae model system could help us to elucidate the pleiotropic
e¡ect of PyV LT antigen, to detect other protein^protein in-
teractions and to determine their functional consequences.
2. Materials and methods
2.1. Media and strains
S. cerevisiae strains BY4742 (MATK ; his3v1 ; leu2v0 ; lys2v0 ;
ura3v0) from EUROSCARF, BY4741-TUB3-GFP (MATa ; TUB3-
GFP, his3v1 ; leu2v0 ; met15v0 ; ura3v0) kindly provided by L. Synek
(Charles University, Prague, Czech Republic), LRA85 (MATK ;
cdc35-11 ; leu2v0 ; ura3v52 ; his4v0) and JC482 (MATK ; leu2v0 ;
ura3v52 ; his4v0) kindly provided by K. Tatchell (Louisiana State
University, USA) were used. Escherichia coli XL1-blue strain: recA1
endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [FPproAB lacI q
ZDM15 Tn10 (Tetr)] (Stratagene) was used for propagation of plas-
mids.
Yeast cells were grown in liquid minimal medium (MM) (0.1%
KH2PO4, 0.05% MgSO4, 0.5% (NH4)2SO4, 0.1% Wickerham’s solu-
tion [36] with appropriate supplements (50 mg/l amino acids and 40
mg/l bases) and either 2% glucose (MMGlc) or 2% galactose
(MMGal). Alternatively, solid media MAGlc (MMGlc, 2% agar)
and MAGal (MMGal, 2% agar) were used.
2.2. Preparation of the recombinant plasmid
The recombinant p425GAL1-LT plasmid was constructed by liga-
tion of the BamHI^BamHI fragment containing the intronless LT
gene cut from p423GAL1-LT and yeast shuttle expression vector
p425GAL1 [37] cut with BamHI. The recombinant p423GAL1-LT
plasmid was constructed by ligation of the EcoRI^EcoRI and
EcoRI^SalI fragments containing the intronless LT gene cut from
pGBT9LT [38] together with yeast shuttle expression vector
p423GAL1 [37] cut with EcoRI and SalI. DNA recombination tech-
niques and agarose gel electrophoresis were performed according to
[39] and E. coli electroporation as described in [40].
2.3. Yeast cell transformation
Transformation of yeast cells was performed using the lithium ace-
tate method according to [41].
2.4. Preparation of yeast cell lysates
The MMGalHisUraLys (500 ml) was inoculated at starting concen-
tration 2U107 cells/ml and cell suspension was cultivated for 48 h.
Then, the cell culture was centrifuged, the cell sediment transferred
into a stirring dish and the cells disrupted by stirring under liquid
nitrogen. The RIPA bu¡er (150 mM NaCl, 5 mM ethylenediamine
tetraacetic acid (EDTA) pH 8.0, 50 mM Tris^HCl pH 7.4, 0.05% NP-
40, 1% deoxycholic acid, 1% Triton X-100) with 0.01% sodium do-
decyl sulfate (SDS) was added (approximately 0.5 ml) and the mixture
was stirred again into a snow-like consistency. After subsequent thaw-
ing, the lysate was transferred into a tube and cell debris was removed
by centrifugation.
2.5. Western blot analysis
Proteins resolved on Laemmli SDS^polyacrylamide gel electropho-
resis (PAGE) were electrotransferred onto a nitrocellulose ¢lter using
blotting bu¡er (1.44% glycine, 0.3% Tris, 20% methanol) with 0.1%
SDS according to [39]. For detection of LT antigen, a mix of C1 and
C4 (1:1) rat monoclonal antibodies against the common region of
PyV T antigens was applied as primary antibody and anti-rat IgG
antibody conjugated with peroxidase as secondary antibody. Anti-LT
antibodies were kindly provided by Prof. Beverly Gri⁄n (St. Mary’s
Hospital, London, UK).
2.6. Indirect immuno£uorescence and 4,6-diamidino-2-phenyl-indole
(DAPI) staining of yeast cells
Immunodetection was performed as described in [42]. Brie£y,
S. cerevisiae BY4742/p425GAL1-LT-induced cell suspension was in-
cubated for 5 min with 30 mM ethyleneglycol-bis-(L-aminoethylether)-
N,N,NP,NP-tetraacetic acid (EGTA) (pH 7.0) and pepstatin (20 Wg/ml)
at 28‡C. Yeast cells were ¢xed with paraformaldehyde and sphero-
plasts were prepared by digestion with zymolyase (200 Wg/ml) in KPC
(33 mM citric acid, 0.13 M K2HPO4, pH 5.9) and pepstatin (20 Wg/ml)
for 60 min. Cells were washed twice in PEMI (0.1 M PIPES, 5 mM
EGTA, 5 mM MgCl2, pH 6.9 and pepstatin (10 Wg/ml)). Cell mem-
branes were permeabilized with 1% Triton X-100 in PEMI. After
washing in PEMI and pre-incubation in 1% bovine serum albumin
in PEMI for 10 min, a mix of C1 and C4 (1:1) rat monoclonal anti-
bodies against the common region of PyV T antigens (in 1% bovine
serum albumin (BSA) in PEMI) was applied as primary antibody for
1 h at room temperature. Cells were washed twice in PEMI and the
bound antibodies were detected by 45-min incubation with goat anti-
rat IgG conjugated with Alexa Fluor 488 (green, Molecular Probes).
After the ¢nal wash in PEMI, cells were resuspended in mounting
medium (0.1% (w/v) p-phenylenediamine in 100 mM Tris^HCl, 100
mM NaCl, 5 mM MgCl2, pH 9.5 and 0.5 ug/ml of DAPI freshly
prepared).
2.7. Detection of LT antigen production in yeast cells within a colony
A colony was resuspended in distilled water, plated on MAGal and
incubated for 11 days for monocolony development. A replica nitro-
cellulose ¢lter was prepared and the immunodetection of LT antigen
(using antibodies described in Section 2.5) was performed as described
[43].
3. Results and discussion
3.1. Production of PyV LT antigen in yeast cells
PyV LT gene was cloned under the yeast inducible GAL1
promoter in the high-copy 2W-based plasmid p425GAL1, as
described in Section 2.2. S. cerevisiae strain BY4742 was
transformed by recombinant p425GAL1-LT (p425GLT) or
by the ‘empty’ p425GAL1 (p425G) plasmid. Transformants
were selected on MAGlcHisUraLys. The ¢rst colonies formed
by BY4742/p425GLT (BY/p425GLT) or by BY4742/p425G
(BY/p425G) appeared approximately 2^3 days after the trans-
formation. The LT antigen gene expression from the GAL1
promoter was induced by the transfer of yeast cells from glu-
cose- to galactose-containing MMHisUraLys as described in
Fig. 1. Western blot of PyV LT antigen produced in S. cerevisiae vi-
sualized by a mix of C1 and C4 (1:1) anti-LT antibodies and sec-
ondary anti-rat antibody conjugated with peroxidase. Molecular
weight marker (lane M), lysate of BY/p425GLT (lane 1), lysate of
BY/p425G (lane 2).
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Section 2.4. The amount of 3U109 cells was harvested and the
presence of LT antigen con¢rmed by Western blot using a mix
of rat monoclonal anti-PyV LT antibodies, as described in
Section 2.5 (Fig. 1).
3.2. Subcellular localization of PyV LT antigen using indirect
immuno£uorescence in yeast
For the indirect immuno£uorescence procedure, the cells
were harvested 8 h post-induction. LT antigen was visualized
with anti-LT antibody (green), whole cell DNA was stained
by DAPI (blue). Fig. 2 clearly shows nuclear localization of
LT antigen within yeast cells and its accumulation in, yet non-
identi¢ed, subnuclear foci. Interestingly, similar non-random
LT antigen distribution was also observed in mammalian cells
during the late phase of PyV infection (Plevka et al., our
unpublished results).
3.3. Growth inhibition of yeast cells expressing the PyV LT
antigen
On the galactose agar medium, the colonies of the strain
expressing LT antigen (BY/p425GLT) appeared with a delay
of approximately 6 days in comparison with the colonies of
the strain containing the control BY/p425G plasmid (without
the LT gene). Both strains grew with similar e⁄ciency on the
glucose-containing agar medium (Fig. 3). The inhibition was
also observed when LT-expressing cells were grown in liquid
culture (data not shown). This observation implicates that the
expression of LT antigen inhibits growth of the yeast cells.
However, more detailed analyses surprisingly revealed that
this growth inhibition had only a temporary character: The
‘distinction’ (presumably caused by the LT growth inhibition)
between colonies formed by BY/p425GLT and those formed
by BY/p425G gradually diminished. After a prolonged time of
incubation (approximately 16 days), the BY/p425GLT colo-
nies reached the size of colonies formed by BY/p425G
(Fig. 4A). About 98^100% of monocolonies formed by cells
taken from a 16-day-old BY/p425GLT colony still produced
LT antigen, thus indicating that the escape from the growth
arrest was not due to the loss of LT antigen (Fig. 5). This
implies that BY/p425GLT cells are able to overcome the in-
hibition e¡ect of LT antigen. Despite the fact that the mech-
anism is unknown, there are basically two possible explana-
tions: either the decrease of the plasmid copy number inside
the cells causes the decrease of LT antigen below the inhibi-
tory level, or the yeast cells are somehow able to adapt and to
neutralize a toxic e¡ect of LT antigen. Minimal appearance of
cells with no detectable LT antigen (0^2% of cells per colony)
makes the adaptation hypothesis more probable.
Fig. 2. Indirect immuno£uorescence of yeast cells expressing LT
antigen (BY4742/p425GLT) (A) and control (BY4742/p425G) (B).
LT was visualized with anti-LT antibody and anti-rat antibody con-
jugated with Alexa Fluor 488 (green). Whole cell DNA was stained
by DAPI (blue).
Fig. 3. Expression of the LT protein inhibits growth of yeast cells. Cells were plated on the agar medium with the same e⁄ciency.
BY/p425GLT and BY/p425G on induction medium (MAGal) (A) and on non-induction medium (MAGlc) (B).
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The intensity of LT signals of individual colonies in Fig. 5B
does not re£ect the amount of the LT protein, due to unequal
replica plating and autolysis e⁄ciency of colonies of di¡erent
sizes.
Similarly, e¡ective adaptation of yeast cells to the inhibitory
e¡ect of the VP1 protein of PyV was observed [44]. However,
in comparison to VP1 (subcloned into the same plasmid as LT
antigen), LT antigen exhibits more e⁄cient inhibition of yeast
cells at an early time of colony development (data not shown).
This could be caused by the fact that, in contrast to VP1,
which is the major structural protein of PyV capsid, the LT
antigen is a regulatory protein, which can a¡ect various cel-
lular processes of higher eukaryotes, including cell cycle reg-
ulation. Experiments are underway to identify LT interac-
tion(s) responsible for the observed inhibition.
3.4. Expression of mouse PyV LT antigen causes
morphological changes in S. cerevisiae cells
The production of LT antigen causes alterations of the
morphology of monocolonies formed by BY/p425GLT. These
monocolonies are heterogeneous in size and ‘shrunken’
in comparison with ‘smooth’ monocolonies formed by
BY/p425G cells (Fig. 6). The ‘shrunken’ monocolony mor-
phology is not observed when cells grow on non-induction
glucose medium (Fig. 6). The e¡ect of LT antigen on the
morphology of ‘giant’ colonies (i.e. colonies arising from a
cell suspension spotted on agar [45]) is also visible. ‘Giant’
colonies formed by cells producing LT antigen have a dentate
rim and are more £at in comparison with the BY/p425G
‘giant’ colonies (data not shown).
The cells of monocolonies growing on induction medium
MAGalHisUraLys as well as cells from liquid MMGalHis-
UraLys were observed under a light microscope. The distinct
morphology changes of the subpopulation of BY/p425GLT
cells were observed in comparison to BY/p425G cells, thus
indicating the e¡ect of LT antigen on the cell morphology
and cell cycle (Fig. 7). These ‘monstrous’ cells also exhibited
modi¢cations in microtubule arrangement as indicated in
Fig. 8.
In contrast to the gradual escape of older colonies from the
inhibition e¡ect of LT antigen (see above), the colony mor-
phology of BY/p425GLT di¡ered from that of BY/p425G
during the entire estimated period (Fig. 4C). Also, the mor-
phologically changed cells were present in colonies of di¡erent
age (Fig. 4B). These observations suggest that despite possible
BY/p425GLT colony growth adaptation, the LT antigen
present within most of the cells might a¡ect the cell division,
possibly in£uencing also their budding pattern and cell sepa-
ration.
A very similar e¡ect on cell morphology was observed when
the LT antigen of SV40 was expressed in S. cerevisiae [46].
An SV40 LT antigen deletion mutant, lacking 150 amino
acids at the carboxy-end, did not cause the aberrant cell mor-
phology. This indicates that the carboxy-end region of SV40
LT antigen, referred to as the host range/helper function do-
main, was responsible for yeast cell cycle disruption [47].
However, SV40 LT antigen contains approximately 70 ami-
no acids at its carboxy-end that have no homology with any
sequences in PyV LT antigen.
Fig. 4. Transient growth inhibition of yeasts expressing LT antigen
(BY/p425GLT). The LT antigen inhibition of yeast cells is only
transient (A). There is altered morphology of yeast cells during the
entire examined time period (B), LT antigen producing monocolo-
nies grown up to the size of the control ones have di¡erent mor-
phology (C).
Fig. 5. Monocolonies formed by cells taken from a 16-day-old BY/p425GLT colony still produce LT antigen. 11-day colonies grown on MAG-
alHisUraLys (A) transferred by replica plating on nitrocellulose ¢lters, lysed and immunostained with LT speci¢c antibody (B). A and B merge
(C).
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3.5. Yeast growth inhibition by PyV LT antigen depends on the
level of intracellular cAMP
The p425GLT plasmid was introduced by a standard
procedure (with omitted heat shock step) into the cdc35-11
(adenylate cyclase) thermosensitive LRA85 mutant strain.
Transformants carrying the plasmid were selected on MAGlc-
HisUra at a permissive temperature, 24‡C. Selected trans-
formants were plated on MAGalHisUra agar and parallel
plates were incubated at three di¡erent temperatures: (i) per-
missive temperature, 24‡C, (ii) semi-permissive temperature,
28‡C and (iii) non-permissive temperature, 37‡C. After
6 days, substantial inhibition of cell growth was evident at
the permissive temperature. On the contrary, at semi-permis-
sive temperature of 28‡C, where the level of intracellular
cAMP was decreased, the cells carrying the p425GLT plasmid
and producing LT antigen grew faster than p425GLT cells
growing at the permissive temperature (Fig. 9A). Also, the
morphology of colonies growing at the semi-permissive tem-
perature (Fig. 9B) is less ‘shrunken’ than the morphology of
colonies at the permissive temperature. On the contrary, the
growth inhibition and shrunken colony morphology of the
isogenic parental strain, JC482, containing the p425GLT plas-
mid was the same at 24 and 28‡C (data not shown). These
observations imply that the inhibition e¡ect of LT antigen is
dependent on the intracellular cAMP level. The level of intra-
cellular cAMP can be in£uenced by at least three di¡erent
signalling pathways, i.e. RAS, GPA2, and MAP kinases.
Very similar results of cAMP dependence were observed
when the adenoviral E1A protein was expressed in S. cerevi-
siae cdc35 (adenylate cyclase) and cdc25 (RAS guanyl-nucle-
otide exchange factor) thermosensitive mutants [8]. Further
studies using de¢ned mutants in these three aforementioned
pathways should determine the signalling pathway involved.
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Fig. 9. The inhibition e¡ect of the LT protein is cAMP-dependent. LRA85/p425GLT and LRA85/p425G at permissive (24‡C) and semi-permis-
sive (28‡C) temperature (A) and a detail of a monocolony (B).
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